General Information of Drug Off-Target (DOT) (ID: OTG1EI22)

DOT Name LHFPL tetraspan subfamily member 3 protein (LHFPL3)
Synonyms Lipoma HMGIC fusion partner-like 3 protein
Gene Name LHFPL3
Related Disease
Adult glioblastoma ( )
Glioblastoma multiforme ( )
Glioma ( )
Neoplasm ( )
Obesity ( )
Acute myelogenous leukaemia ( )
Bipolar disorder ( )
Gout ( )
UniProt ID
LHPL3_HUMAN
3D Structure
Download
2D Sequence (FASTA)
Download
3D Structure (PDB)
Download
Pfam ID
PF10242
Sequence
MPGAAAAAAAAAAAMLPAQEAAKLYHTNYVRNSRAIGVLWAIFTICFAIVNVVCFIQPYW
IGDGVDTPQAGYFGLFHYCIGNGFSRELTCRGSFTDFSTLPSGAFKAASFFIGLSMMLII
ACIICFTLFFFCNTATVYKICAWMQLTSAACLVLGCMIFPDGWDSDEVKRMCGEKTDKYT
LGACSVRWAYILAIIGILDALILSFLAFVLGNRQDSLMAEELKAENKVLLSQYSLE

Molecular Interaction Atlas (MIA) of This DOT

8 Disease(s) Related to This DOT
Disease Name Disease ID Evidence Level Mode of Inheritance REF
Adult glioblastoma DISVP4LU Strong Biomarker [1]
Glioblastoma multiforme DISK8246 Strong Biomarker [1]
Glioma DIS5RPEH Strong Biomarker [2]
Neoplasm DISZKGEW Strong Biomarker [2]
Obesity DIS47Y1K Strong Genetic Variation [3]
Acute myelogenous leukaemia DISCSPTN moderate Genetic Variation [4]
Bipolar disorder DISAM7J2 moderate Genetic Variation [5]
Gout DISHC0U7 Limited Genetic Variation [6]
------------------------------------------------------------------------------------
⏷ Show the Full List of 8 Disease(s)
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This DOT
3 Drug(s) Affected the Post-Translational Modifications of This DOT
Drug Name Drug ID Highest Status Interaction REF
Valproate DMCFE9I Approved Valproate increases the methylation of LHFPL tetraspan subfamily member 3 protein (LHFPL3). [7]
Benzo(a)pyrene DMN7J43 Phase 1 Benzo(a)pyrene increases the methylation of LHFPL tetraspan subfamily member 3 protein (LHFPL3). [8]
Octanal DMTN0OK Investigative Octanal increases the methylation of LHFPL tetraspan subfamily member 3 protein (LHFPL3). [9]
------------------------------------------------------------------------------------

References

1 Identification of novel genetic alterations in samples of malignant glioma patients.PLoS One. 2013 Dec 16;8(12):e82108. doi: 10.1371/journal.pone.0082108. eCollection 2013.
2 MiR-218-5p targets LHFPL3 to regulate proliferation, migration, and epithelial-mesenchymal transitions of human glioma cells.Biosci Rep. 2019 Mar 1;39(3):BSR20180879. doi: 10.1042/BSR20180879. Print 2019 Mar 29.
3 A genome-wide association study on obesity and obesity-related traits.PLoS One. 2011 Apr 28;6(4):e18939. doi: 10.1371/journal.pone.0018939.
4 Genome-wide haplotype association study identify the FGFR2 gene as a risk gene for acute myeloid leukemia.Oncotarget. 2017 Jan 31;8(5):7891-7899. doi: 10.18632/oncotarget.13631.
5 Genetic variants associated with response to lithium treatment in bipolar disorder: a genome-wide association study.Lancet. 2016 Mar 12;387(10023):1085-1093. doi: 10.1016/S0140-6736(16)00143-4. Epub 2016 Jan 22.
6 Gout and type 2 diabetes have a mutual inter-dependent effect on genetic risk factors and higher incidences.Rheumatology (Oxford). 2012 Apr;51(4):715-20. doi: 10.1093/rheumatology/ker373. Epub 2011 Dec 16.
7 Integrative omics data analyses of repeated dose toxicity of valproic acid in vitro reveal new mechanisms of steatosis induction. Toxicology. 2018 Jan 15;393:160-170.
8 Air pollution and DNA methylation alterations in lung cancer: A systematic and comparative study. Oncotarget. 2017 Jan 3;8(1):1369-1391. doi: 10.18632/oncotarget.13622.
9 DNA Methylome Analysis of Saturated Aliphatic Aldehydes in Pulmonary Toxicity. Sci Rep. 2018 Jul 12;8(1):10497. doi: 10.1038/s41598-018-28813-z.